Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-23

Clinical Trial Update: A Study of Pemetrexed in Children With Recurrent Cancer [Phase 2]

View source ↗

Summary

Pemetrexed was studied in a Phase 2 trial in children with recurrent cancer across several pediatric tumor types, including osteosarcoma and medulloblastoma. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteosarcoma, Medulloblastoma | Phase 2 | Status: COMPLETED | Results posted: 2011-02-23